The Clinical and Cost Considerations of Bisphosphonates in Preventing Bone Complications in Patients with Metastatic Breast Cancer or Multiple Myeloma

Author： McCloskey E.V.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.61, Iss.9, 2001-01, pp. : 1253-1274

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pegylated Liposomal Doxorubicin: A Review of its use in Metastatic Breast Cancer, Ovarian Cancer, Multiple Myeloma and AIDS-Related Kaposi's Sarcoma

By Duggan Sean T.   Keating Gillian M.  

Drugs, Vol. 71, Iss. 18, 2011-12 ,pp. : 2531-2558

Adis International

Access to resources Recommend Favorite

Clodronate: A Review of its Use in the Prevention of Bone Metastases and the Management of Skeletal Complications Associated with Bone Metastases in Patients with Breast Cancer

By Toni M. Dando   Lynda R. Wiseman  

Drugs & Aging, Vol. 21, Iss. 14, 2004-01 ,pp. : 949-962

Adis International

Access to resources Recommend Favorite

Challenging the Current Approaches to Multiple Myeloma-Related Bone Disease: From Bisphosphonates to Target Therapy

By  

Current Cancer Drug Targets, Vol. 9, Iss. 7, 2009-01 ,pp. : 854-870

Bentham Science Publishers

Access to resources Recommend Favorite

Breast Cancer Management: Quality-of-Life and Cost Considerations

By Radice D.   Redaelli A.  

PharmacoEconomics, Vol. 21, Iss. 6, 2003-01 ,pp. : 383-396

Adis International

Access to resources Recommend Favorite

Preventing GI complications only cost effective in patients at risk

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 462, 2004-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite